Cancer - Gastrointestinal (Stomach) Cancer Report Provides The User With Real Detail On Drug Pipelines, By Company And By Stage
Posted on: Friday, 7 November 2008, 12:00 CST
Research and Markets (http://www.researchandmarkets.com/research/464d2f/cancer_gastroint) has announced the addition of the "Cancer - Gastrointestinal (Stomach) Cancer" report to their offering.
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Key Topics Covered:
-Gastrointestinal (Stomach) Cancer Pipeline Overview -Top Companies in late stage Gastrointestinal (Stomach) Cancer Projects
-Top Companies in early stage Gastrointestinal (Stomach) Cancer Projects
-Pipeline Revenue
For more information visit http://www.researchandmarkets.com/research/464d2f/cancer_gastroint
Source: Life Science Analytics
Source: Business Wire
Related Articles
- China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS
- China Biologic Products Appoints Director of Research and Development
- ImClone and Sanofi-Aventis Settle Patent Litigation With Yeda Research and Development Corporation
- EaglePicher Technologies Opens Research and Development Center in Joplin, Mo.
- Nanotherapeutics and the Vaccine Branch of the National Cancer Institute Enter Into Cooperative Research and Development Agreement (CRADA)
- EPIX Pharmaceuticals Announces New Additions to Research and Development Organization
- Point Therapeutics Presents Talabostat's Novel Dual Mechanism of Action During Research and Development Day
- BladeLogic Opens Research and Development Facility in India; Pune Facility to Also Serve As Regional Sales & Marketing Headquarters
- NanoViricides Hires Vice President of Research and Development
- Jim Mitchell to Lead Sun's DARPA HPCS Research and Development Program
 |
 |
User Comments (0)
RSS Feeds